227 related articles for article (PubMed ID: 16180235)
21. DEK protein level is a biomarker of CD138positive normal and malignant plasma cells.
Çalışkaner ZO; Çakar T; Özçelik E; Özdilek A; Kim AS; Doğan Ö; Bosompem A; Grosveld G; Saka B; Kandilci A
PLoS One; 2017; 12(5):e0178025. PubMed ID: 28558048
[TBL] [Abstract][Full Text] [Related]
22. Amplification and overexpression of E2F3 in human bladder cancer.
Feber A; Clark J; Goodwin G; Dodson AR; Smith PH; Fletcher A; Edwards S; Flohr P; Falconer A; Roe T; Kovacs G; Dennis N; Fisher C; Wooster R; Huddart R; Foster CS; Cooper CS
Oncogene; 2004 Feb; 23(8):1627-30. PubMed ID: 14716298
[TBL] [Abstract][Full Text] [Related]
23. DEK proto-oncogene expression interferes with the normal epithelial differentiation program.
Wise-Draper TM; Morreale RJ; Morris TA; Mintz-Cole RA; Hoskins EE; Balsitis SJ; Husseinzadeh N; Witte DP; Wikenheiser-Brokamp KA; Lambert PF; Wells SI
Am J Pathol; 2009 Jan; 174(1):71-81. PubMed ID: 19036808
[TBL] [Abstract][Full Text] [Related]
24. Minimal 16q genomic loss implicates cadherin-11 in retinoblastoma.
Marchong MN; Chen D; Corson TW; Lee C; Harmandayan M; Bowles E; Chen N; Gallie BL
Mol Cancer Res; 2004 Sep; 2(9):495-503. PubMed ID: 15383628
[TBL] [Abstract][Full Text] [Related]
25. DEK oncogene expression during normal hematopoiesis and in Acute Myeloid Leukemia (AML).
Logan GE; Mor-Vaknin N; Braunschweig T; Jost E; Schmidt PV; Markovitz DM; Mills KI; Kappes F; Percy MJ
Blood Cells Mol Dis; 2015 Jan; 54(1):123-31. PubMed ID: 25128083
[TBL] [Abstract][Full Text] [Related]
26. DEK proto-oncogene is highly expressed in astrocytic tumors and regulates glioblastoma cell proliferation and apoptosis.
Feng T; Liu Y; Li C; Li Z; Cai H
Tumour Biol; 2017 Jul; 39(7):1010428317716248. PubMed ID: 28670979
[TBL] [Abstract][Full Text] [Related]
27. Kif14 overexpression accelerates murine retinoblastoma development.
O'Hare M; Shadmand M; Sulaiman RS; Sishtla K; Sakisaka T; Corson TW
Int J Cancer; 2016 Oct; 139(8):1752-8. PubMed ID: 27270502
[TBL] [Abstract][Full Text] [Related]
28. Association of E2F3 expression with clinicopathological features of Wilms' tumors.
An Q; Wang Y; An R; Li Y; Yao T; Zhai B; Sun X
J Pediatr Surg; 2013 Nov; 48(11):2187-93. PubMed ID: 24210184
[TBL] [Abstract][Full Text] [Related]
29. Real-Time PCR analysis of af4 and dek genes expression in acute promyelocytic leukemia t (15;17) patients.
Savli H; Sirma S; Nagy B; Aktan M; Dincol G; Salcioglu Z; Sarper N; Ozbek U
Exp Mol Med; 2004 Jun; 36(3):279-82. PubMed ID: 15272241
[TBL] [Abstract][Full Text] [Related]
30. Chromatin remodelers HELLS and UHRF1 mediate the epigenetic deregulation of genes that drive retinoblastoma tumor progression.
Benavente CA; Finkelstein D; Johnson DA; Marine JC; Ashery-Padan R; Dyer MA
Oncotarget; 2014 Oct; 5(20):9594-608. PubMed ID: 25338120
[TBL] [Abstract][Full Text] [Related]
31. Genomic gains on chromosome 1q in retinoblastoma: consequences on gene expression and association with clinical manifestation.
Gratias S; Schüler A; Hitpass LK; Stephan H; Rieder H; Schneider S; Horsthemke B; Lohmann DR
Int J Cancer; 2005 Sep; 116(4):555-63. PubMed ID: 15825178
[TBL] [Abstract][Full Text] [Related]
32. Minimal regions of chromosomal imbalance in retinoblastoma detected by comparative genomic hybridization.
Chen D; Gallie BL; Squire JA
Cancer Genet Cytogenet; 2001 Aug; 129(1):57-63. PubMed ID: 11520568
[TBL] [Abstract][Full Text] [Related]
33. CDKN1C (p57KIP2) mRNA expression in human retinoblastomas.
Madhavan J; Mallikarjuna K; Vikas K; George R; Bremner R; Kumaramanickavel G
Ophthalmic Genet; 2010 Sep; 31(3):141-6. PubMed ID: 20565244
[TBL] [Abstract][Full Text] [Related]
34. Regulation of DEK expression by AP-2α and methylation level of DEK promoter in hepatocellular carcinoma.
Qiao MX; Li C; Zhang AQ; Hou LL; Yang J; Hu HG
Oncol Rep; 2016 Oct; 36(4):2382-90. PubMed ID: 27499261
[TBL] [Abstract][Full Text] [Related]
35. The human DEK proto-oncogene is a senescence inhibitor and an upregulated target of high-risk human papillomavirus E7.
Wise-Draper TM; Allen HV; Thobe MN; Jones EE; Habash KB; Münger K; Wells SI
J Virol; 2005 Nov; 79(22):14309-17. PubMed ID: 16254365
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of DEK gene is correlated with poor prognosis in hepatocellular carcinoma.
Yi HC; Liu YL; You P; Pan JS; Zhou JY; Liu ZJ; Zhang ZY
Mol Med Rep; 2015 Feb; 11(2):1318-23. PubMed ID: 25351213
[TBL] [Abstract][Full Text] [Related]
37. A Meta-Analysis of Retinoblastoma Copy Numbers Refines the List of Possible Driver Genes Involved in Tumor Progression.
Kooi IE; Mol BM; Massink MP; de Jong MC; de Graaf P; van der Valk P; Meijers-Heijboer H; Kaspers GJ; Moll AC; Te Riele H; Cloos J; Dorsman JC
PLoS One; 2016; 11(4):e0153323. PubMed ID: 27115612
[TBL] [Abstract][Full Text] [Related]
38. Microarray analysis and biochemical correlations of oxidative stress responsive genes in retinoblastoma.
Vandhana S; Lakshmi TS; Indra D; Deepa PR; Krishnakumar S
Curr Eye Res; 2012 Sep; 37(9):830-41. PubMed ID: 22668346
[TBL] [Abstract][Full Text] [Related]
39. The involvement of cellular proliferation status in the expression of the human proto-oncogene DEK.
Ageberg M; Gullberg U; Lindmark A
Haematologica; 2006 Feb; 91(2):268-9. PubMed ID: 16461319
[TBL] [Abstract][Full Text] [Related]
40. The DEK protein--an abundant and ubiquitous constituent of mammalian chromatin.
Waldmann T; Scholten I; Kappes F; Hu HG; Knippers R
Gene; 2004 Dec; 343(1):1-9. PubMed ID: 15563827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
